Therapeutic Apheresis in South America

Similar documents
Tuberculosis surveillance and health information system in Brazil,

Implementation Status & Results Brazil AIDS-SUS (National AIDS Program - National Health Service) (P113540)

A PRIMER ON APHERESIS MEDICINE

Paired Comparison of Therapeutic Plasma Exchange using Fenwal Amicus vs. TerumoBCT Spectra Optia

Potential expansion of Zika virus in Brazil: analysis from migratory networks

CORPORATE PROGRAM AND EXHIBITOR GUIDE CORPORATE PROGRAM AND EXHIBITOR GUIDE

corporate Conference San Francisco 15th WAA Congress at the ASFA 2014 Annual Meeting HYATT REGENCY SAN FRANCISCO April 2-5, 2014

Therapeutic Apheresis. SEABB Courtney Hopkins, D.O. American Red Cross, Southern Region

Zika virus transmission: ECDC adaptation of WHO's Zika virus country classification scheme 1

Review of New Platforms for Blood Prime

Welcome to esessions. Presented by CaridianBCT. PN CaridianBCT

THERAPEUTIC APHERESIS IN AFRICA

JC Hofmann, MD 1,2 ; KM Grant, MD 3 ; DD Kiprov, MD 1,2. Apheresis Care Group, 2. Division of Immunotherapy, 3

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL

Brazilian Academic Consortium for Integrative Health. Ricardo Ghelman, MD, PhD Chair

Grupo Fleury announces the acquisition of Grupo Papaiz, entering the dental diagnostics market. September 28th, 2012

Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006

Original Article Artigo Original

34 th Annual Meeting of ASFA, May 22-25, 2013, Denver, CO

Sixth University Global Partnership Network (UGPN) Annual Conference

Hepatocellular Carcinoma and Other Hepatic Diseases in Santa Cataaina State

APHERESIS PROCEDURES. Worldwide implemented nowadays. Most of Asian Countries also involved. The usage of this procedure varies between countries.

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Thrombocytosis. Leukemias Cell Therapies

IMPACT OF A DATA-DRIVEN PREDICTION ALGORITHM FOR BLOOD VOLUME PROCESSING IN PERIPHERAL BLOOD STEM CELL COLLECTION IN UNRELATED (NMDP) HPC DONORS

Leukopak 101: A Brief Review of Apheresis

Spanish Info Service for Rare Disease

Senior Management Team Meeting Target setting in Latin America

Algorithms to predict CD34+ cell collection with the new generation of cell separator machines

Academic Research in LA

Cigna Drug and Biologic Coverage Policy

APHERESIS MEDICAL POLICY. Policy Number: 2014T0136S Effective Date: August 1, Page. Table of Contents

Genetic Disorders and Congenital Defects in Latin America and the Caribbean

Apheresis: Clinical Indications

Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006

Soliris (eculizumab) DRUG.00050

Colorectal Cancer Prevention Hospital Universitário São Paulo University

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

HIV-1 Transmitted Drug Resistance in Latin America and the Caribbean: What Do We Know?

APHERESIS. Policy Number: OTH027 Effective Date: March 1, 2018

Clinical Policy Title: Plasmapheresis and plasma exchange

Case Study - Turma Do Bem- Dentista do Bem

Therapeutic Apheresis Services Annual Review 2016/17

Travel Health Alert. Argentina Over 79,400 probable cases (10 deaths) of dengue fever have been reported from 21 provinces during 2016.

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting

INTERCEPT Blood System pathogen reduction system Process Specifications for Platelets and Plasma

Current Status in Latin America

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

Histiocytosis in Argentina Since 1991

Medical Policy. Description/Scope. Position Statement

Transfusion Risk for Hepatitis B, Hepatitis C and HIV in the State of Santa Catarina, Brazil,

Subject: Plasmapheresis for Renal and Non-renal Indications. Original Effective Date: 4/24/13. Guidance Number: MCG- 134 Revision Date(s): 4/24/13

Jackeline Christiane Pinto Lobato 1*, Pauline Lorena Kale 1, Luis Guillermo Coca Velarde 2, Moyses Szklo 3 and Antonio José Leal Costa 1

Emergency Plan of Action (EPoA) Brazil: Yellow Fever

The role of DEBRA and regional associations in Brazil, a continental country. Dra. Jeanine Magno Dermatopediatrist DEBRA Brasil (president)

World Drug Report 2008: Paraguay

Turma Do Bem: Dentista do Bem Fabio Bibancos

Hind Al Humaidan, MD, FRCPA Consultant Hematopathologist Director, Blood Bank (DS & TS) / Stem Cell Cord Blood Bank Department of Pathology and

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE

1 Roraima 2Amapá 3 Amazonas 4 Maranhão 5 Pará 6 Ceará 7 Rio Grande do Norte. Northeast Center- Southeast. 26 South

MEDICAL POLICY I. POLICY POLICY TITLE PLASMA EXCHANGE (PE) POLICY NUMBER MP Original Issue Date (Created): December 1, 2010

The New Zealand Experience

XXVI CINP CONGRESS. mood disorders: The application. Gerhard Heinze M.D.

Enel Américas 1Q 2018 results

55th DIRECTING COUNCIL

Objective: Perceive an accurate profile of echocardiographic services offered in Brazil.

Report and Action Plan

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

APHERESIS. Guideline Number: MMG003.G Effective Date: January 1, 2018

Blood and Marrow Transplant (BMT) for Sickle Cell Disease

Clinical Policy Title: Plasmapheresis and plasma exchange

Change in Therapeutic Apheresis Practices: Role of Continuing Medical Education (CME)

Target audience. Chair. Xxx Xxx

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

Disparities in female breast cancer mortality rates in Brazil between 1980 and 2009

PYRIDOXOL, PYRIDOXAL AND PYRIDOXAMINE (VITAMIN B 6 VITAMERS) CONTENT IN BRAZILIAN DEHYDRATED BEE POLLEN

Blood Components & Indications for Transfusion. Neda Kalhor

6 Hemapheresis. In hemapheresis, whole. Separation Devices. Separation by Centrifugation

Chapter 1 Section 3.1

Policy #: 100 Latest Review Date: June 2014

Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India

Brazil fears birth defects linked to mosquitoborne

Therapeutic Apheresis and Specialized Procedures in Apheresis: an overview

Original Article objective: Methods: Results: Conclusion: key words: Mailing Address: Antonio de padua Mansur 586

2012 NHLBI Symposium State of the Science in Therapeutic Apheresis the roadmap for the future is here...

Corporate Medical Policy

Challenges for dengue control in Brazil: overview of socioeconomic and environmental factors associated with virus circulation

The New Approach to Assignment of ASFA Categories Introduction to the Fourth Special Issue: Clinical Applications of Therapeutic Apheresis

Principles of Plasma Exchange, Applications & Practical issues

Choices. Patient Education. Making the treatment decision. Overview. How do you define quality of life?

CHANGE M MAY 22, CHAPTER 1 Section 3.1, pages 1 through 4 Section 3.1, pages 1 through 5

Data sharing experience from Zika outbreak in Brazil

Consensus. 2 nd Brazilian Consensus on Chagas Disease, 2015*

1st Postraumatic Bone Defects and Infections in the Musculoeskeletal System ASOCIACION MEDICOS HOSPITAL DEL TRAUMA (ASOMEHT)

DENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo

STEM CELL TRANSPLANT IN PEDIATRICS. Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17

9 th World. Nephrology Conference. Sao Paulo, Brazil August 15-17, Theme: Latest advancements and new-fangled techniques in Nephrology

Blood Group Incompatible Renal Transplantation and Apheresis. Liz Wright Clinical Nurse Specialist Great Ormond Street Hospital NHS FT

Transcription:

Therapeutic Apheresis in South America Alfredo Mendrone Jr, MD, PhD Fundação Pró-Sangue Hemocentro de SP / University of São Paulo São Paulo - Brazil

Therapeutic Apheresis in Brazil The beginning... Late 80 s No more than five public Hospitals Equipment types Vivacell DIDECO V30 - HAEMONETICS University of São Paulo Vivacell DIDECO LDL apheresis device (KANEKA) A few procedures monthly

Therapeutic Apheresis in Brazil The Beginning... In the 90 s, other apheresis units were created in blood banks along the country It was due time to overspread the benefits of the therapeutic apheresis procedures to other centers and among physicians. How? Inserting topics in the field of apheresis at the Annual National Congress of Hematology Organizing symposia about apheresis medicine in different parts of the country Training professionals involved with the apheresis procedures Presenting lectures and contributing in programs of hematology residents in the field of apheresis medicine

Therapeutic Apheresis in Brazil The Beginning... Participating in annual meetings of other specialties and participating in discussions with many other medical specialists about apheresis applications and complications, in order to share our experience. Stimulating all medical centers to develop standardized operatinational procedures in apheresis field Taking part in discussions about increment in the reimbursement of the procedures to make it more and more accessible Participating and contributing with the elaboration of federal regulations related to transfusion procedures, including apheresis

Therapeutic Apheresis in Brazil Current Situation... We have a specific regulation for apheresis (therapeutic and non therapeutic procedures) The indication of the procedures as well as the planning of therapeutic program for the patient must be discussed with the hematologist of the blood bank The hematologist will be the responsible for the procedures The blood bank must have standardized operational procedures related to apheresis, defined and written The blood bank must register every significant data about the procedure Reimbursement of each therapeutic apheresis procedures = US$ 75,00 disposables, equipment, staff, etc (without the replacement fluid)

BRAZIL = 26 States and 01 Federal District 05 Regions (N, NE, SE, S, MW) Public 72% Private 28%

Therapeutic Apheresis in Brazil and South America Current Situation... In order to obtain a general overview of apheresis activity in Brazil and South America, we developed two different surveys Brazil = A questionnaire was sent to every public regional coordinator blood bank in Brazil, asking about their apheresis activities and difficulties. 32 questionnaires were sent out : 21 out of 32 (65%) were responded accordingly South America = Other questionnaire was developed and sent out to Societies of Hematology in South America 09 questionnaires were sent out to Argentina, Chile, Colombia, Equator, Peru, Venezuela, Bolivia, Uruguay and Paraguay We got some feedback from Argentina, Chile, Colombia, Equator, Uruguay and Venezuela (66%) We have consulted companies that sell apheresis kits in Brazil and South America: TERUMO BCT, FRESENIUS AND CEI (HAEMONETICS).

Therapeutic Apheresis in Brazil and South America Current Situation... The questionnaires were sent out in December/2013 and the responses were received by February/2014 The forms were similar and basically requested information about the procedures and devices The answers were sent by either fax or email The data that will be presented here are the results of these two surveys The participation was completely voluntary

Therapeutic Apheresis in Brazil Current Situation... In 2013, a total of 5,224 therapeutic apheresis procedures were performed in public blood banks in Brazil 4,162 Plasma Exchanges 877 Extracorporeal Photoapheresis 122 RBC Exchanges 46 Leukapheresis 17 Platelet Apheresis

Therapeutic Apheresis in Brazil Current Situation... 4,6% 16,8% 79,6%

Regional Distribution 5,0% From a total of 4,162 plasma exchanges performed 2,435 in Southeast 911 in South 593 in Northeast 221 in North Only 2 in Midwest 0% 59% 22% 14%

Therapeutic Apheresis in Brasil Current Situation... The top 6 diagnoses treated by plasma exchange DISEASE Thrombotic Thrombocytopenic Purpura Neuromyelitis optica of Devic Myasthenia gravis Guillain-Barré Syndrome (before IgG) Severe Cryoglobulinemia Antibody-mediated rejection - renal transplantation ASFA CATEGORY I II I I I I

Therapeutic Apheresis in Brazil Current Situation... On average, 3 4 liters of plasma were removed during each plasma exchange procedures Replaced by equal volume of replacement fluid (1 x 1) Albumin solution 4-5% in the most of diseases FFP for TTP or HUS Electrolyte solution Cryosupernatant plasma was rarely used, only in some cases of thrombotic microangiopathy that had not responded to FFP

Therapeutic Apheresis in Brasil Current Situation... Red Blood Cell Exchanges were performed 122 times 100% in patients with Sickle Cell Disease Treatment of acute complications Prophylaxis for stroke prevention Preoperative management Therapeutic apheresis for cytoreduction was performed 63 times 46 leukocytapheresis in hyperleukocytosis 17 plateletpheresis in thrombocytosis

Therapeutic Apheresis in Brasil Current Situation... DEVICES FOR PERFORMING THERAPEUTIC APHERESIS PROCEDURES NUMBER % HAEMONETICS MCS+ 23 42 TERUMO SPECTRA 19 35 FRESENIUS COM.TEC 8 15 TERUMO OPTIA 4 7 FRESENIUS AS 104 1 2 TOTAL 55

Therapeutic Apheresis in Brazil Current Situation... Extracorporeal Photoapheresis was performed 877 times For chronic GVHD treatment Number of Equipment = 9 (97 procedures for each machine / year) Neither Immunoadsorption nor LDL apheresis was reported in Brazil during the last year

Therapeutic Apheresis in Brazil Current Situation... Stem cell collection 3,137 Procedures For both autologous and allogeneic progenitor hematopoietic cell transplantation Device most frequently utilized: Spectra TERUMO BCT

Therapeutic Apheresis in Brazil Conclusions We still don't have regular and formal reports of activities in apheresis medicine Voluntary reporting is the major impediment to data collecting This was the first nationwide survey performed in Brazil to gather information about apheresis activities We believe that the number of apheresis procedures were underreported due to: the short time we counted on between sending the questionnaires and getting them answered on due date; the private system and a few independent public blood banks were not included in the survey.

Therapeutic Apheresis in Brazil Conclusions Despite the number of underreported procedures, we believe that this survey is representative concerning the public apheresis scenario because we were able to obtain data from the biggest public regional coordinator blood banks in the country It became clear that there are big gaps among different geographic regions The main difficulties and challenges to conduct these procedures are related to the poor reimbursement taking.

ARGENTINA Therapeutic Apheresis in South America Current Situation... Where = Many centers (Buenos Aires, Chaco, Cordoba, Corrientes, Mendonza, Nuequén, Rio Negro, San Juan, Santa Fé, Tucuman) Therapeutic procedures = 2,318 PE = 2,059 RBC exchange = 172 Cytoreduction = 87 Stem Cell Collection = 576

COLOMBIA Therapeutic Apheresis in South America Current Situation... Where = Many centers around the country Plasma Exchange = 1,600 (TTP, GBS, Poisoning) Stem Cell Collection = 550 There is a specific legislation for blood banks in which is included apheresis Responsibility = Hematologist and Nefrologist (many apheresis procedures are performed with devices developed for dialysis) Challenge = Reimbursement

Therapeutic Apheresis in South America Current Situation... CHILE Where = Many centers along the country Therapeutic Apheresis = 1,300 PE = 1,171 PE (TTP, SGB, Renal Transplantation) RBC Exchange = 0 Cytoreduction = 63 Extracorporeal Photoapheresis = 66 Stem Cell Collection = 200 Equipment type Terumo Spectra = 18 Haemonetics MCS+ = 13 Terumo Optia = 4 Fresenius Com.Tec = 2 Amicus = 2

Therapeutic Apheresis in South America Current Situation... EQUATOR Where = Red Cross Ecuatoriana, Seguro Social, Hospital Oncologico Solca, Serhem, Omnihospital, Idytes Plasma Exchange = 400 (Guillain-Barré Syndrome, TTP, Renal transplantation) Stem Cell Collection = 60 Reimbursement = US$ 315,00 / procedures There is no specific legislation for apheresis Responsibility = Hematologist, Neurologist, Surgeons Challenge = Educational programs in apheresis

VENEZUELA Therapeutic Apheresis in South America Current Situation... Where = Many centers around the country Plasma Exchange =? Stem Cell Collection = 80 There is no a specific legislation for apheresis Responsibility = Hematologist Challenge = Reimbursement

URUGUAY Therapeutic Apheresis in South America Current Situation... Where = 14 centers Therapeutic apheresis = 82 procedures PE = 48 Cytapheresis = 34 Stem Cell Collection = 45 There is no a specific legislation for apheresis Responsibility = Hematologist

Therapeutic Apheresis in South America Current Situation... Country Therapeutic Apheresis Stem Cell Collection Brazil 5,224 3,137 Argentina 2,318 576 Colômbia 1,600 550 Chile 1,300 200 Peru 600 100 Equador 400 60 Venezuela? 80 Uruguay 82 45 Total 11,524 4,748

Therapeutic Apheresis in South America Conclusions We received 06 responses from South America (66%) Probably the short time we counted on between sending the questionnaires and getting them answered on due date contributed for the low number of responses No data from Paraguay and Bolivia The results of the survey lead to the conclusion that not only Brazil but also all the countries we collected data from don't have systematic and continuous registration of activities in apheresis medicine Main difficulties and challenges reported were lack of educational programs and appropriate reimbursement

ACKOWLEDGMENTS Brazilian Public Blood Banks: São Paulo, Campinas, Ribeirão Preto, São José do Rio Preto, Botucatú, Marilia, Rio de Janeiro, Paraná, Santa Catarina, Rio Grande do Sul, Ceará, Pernambuco, Sergipe, Alagoas, Amazonas, Bahia, Mato Grosso, Mato Grosso do Sul, Pará e Piauí Argentina, Colombia, Chile, Equator, Venezuela and Uruguay CEI Fresenius Terumo BCT

São Paulo THANK YOU amendrone@gmail.com